AUSTIN, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: With oncology drug-development expenses continuing to rise and regulatory approvals becoming harder to secure, ...
Biotech Beyond Borders Report finds that the biotech industry is grappling with a wave of challenges, including ongoing economic and geopolitical disruption, tightened financing, looming patent cliffs ...
The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Old Pick #17 is a biotech by the name of Tempest Therapeutics (TPST). I want to state that I have chosen to ...
The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #18 is a biotech by the name of Annovis Bio (ANVS)The reason why I wanted to go over this biotech next as ...
Big pharma shares its machine learning models with biotechs, but awaits definitive data on success of artificial intelligence-generated drugs. You have full access to ...
In collaboration with The Column Group, TCG Labs Soleil runs a venture-biotech model with its own R&D hub. (iStock/Getty Images Plus) TCG Labs Soleil has secured $400 million to boost the firm’s ...
The global food system is under strain.
Biotechnology organizations are turning in growing numbers to alternative strategies centered on strengthening the performance of already-approved drugs. Oncotelic Therapeutics is developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results